# DIBBS #SPE2DP-27-T-0270

DLA procurement of 10 units of gabapentin 100 mg capsules

**Posted:** November 10, 2026
**Respond By:** November 16, 2026
**Identifier:** SPE2DP-27-T-0270
**NAICS:** 424210, 325412

DLA Troop Support’s Medical Supply Chain Pharm FSA is seeking gabapentin capsules for medical supply needs.
- Buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; contact listed as James McCullough.
- Product: 10 units of gabapentin capsules, 100 mg, 100-count per unit; NSN 6505-01-387-1892.
- **Approved OEMs and sources:** Cipla USA Inc. (NDC 69097-0813-07), Marlex Pharmaceuticals Inc. (NDC 10135-0644-01), and ScieGen Pharmaceuticals Inc. (NDC 50228-0179-01). These are alternate sources for the same item.
- Requirements: FDA-regulated product; store at 25°C, with permitted excursions from 15°C to 30°C. Shelf life is 36 months and non-extendable.
- Delivery: Single delivery due 20 days after order, FOB destination, with destination inspection and acceptance.

### Description

GABAPENTIN CAPSULES (QTY: 10, NSN: 6505-01-387-1892, Purchase Request: 7019059074)
  Approved Sources:
  - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC
  - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC
  - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0270)